Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.

BACKGROUND:Buruli ulcer is a neglected tropical disease of the skin that is caused by infection with Mycobacterium ulcerans. We recently established an experimental pig (Sus scrofa) infection model for Buruli ulcer to investigate host-pathogen interactions, the efficacy of candidate vaccines and of...

Full description

Bibliographic Details
Main Authors:	Miriam Bolz, Nicolas Ruggli, Nicole Borel, Gerd Pluschke, Marie-Thérèse Ruf
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-04-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4851394?pdf=render

Similar Items

Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease.
by: Miriam Bolz, et al.
Published: (2014-07-01)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.
by: Marie-Thérèse Ruf, et al.
Published: (2016-06-01)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
by: Katharina Röltgen, et al.
Published: (2020-05-01)

Mycobacterium ulcerans persistence at a village water source of Buruli ulcer patients.
by: Martin W Bratschi, et al.
Published: (2014-03-01)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
by: Stéphanie Bibert, et al.
Published: (2017-10-01)

Targeting the Mycobacterium ulcerans cytochrome bc 1 :aa 3 for the treatment of Buruli ulcer
by: Nicole Scherr, et al.
Published: (2018-12-01)

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis.
by: Laurent Marsollier, et al.
Published: (2007-05-01)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
by: Miriam Bolz, et al.
Published: (2016-02-01)

Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana.
by: Katharina Röltgen, et al.
Published: (2010-01-01)

Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer.
by: Claire L Gordon, et al.
Published: (2011-10-01)

Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.
by: Heather R Williamson, et al.
Published: (2012-01-01)

Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control?
by: Manuel T Silva, et al.
Published: (2007-02-01)

Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia.
by: Caroline J Lavender, et al.
Published: (2011-09-01)

Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
by: Kapay Kibadi, et al.
Published: (2010-07-01)

Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
by: Juan Dominguez, et al.
Published: (2023-09-01)

Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer.
by: Anthony J Muleta, et al.
Published: (2021-08-01)

Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia
by: Paul D.R. Johnson, et al.
Published: (2007-11-01)

A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
by: Dezemon Zingue, et al.
Published: (2018-04-01)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
by: Miriam Bolz, et al.
Published: (2015-01-01)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
by: Louisa Warryn, et al.
Published: (2020-06-01)

Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.
by: Paul D R Johnson, et al.
Published: (2005-04-01)

Toward a single-dose cure for buruli ulcer
by: Thomas, Sangeeta Susan, et al.
Published: (2021)

PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d’Ivoire
by: B. G. O. Tchan, et al.
Published: (2023-06-01)

Serologic Response to Culture Filtrate Antigens of Mycobacterium ulcerans during Buruli Ulcer Disease
by: Karen M. Dobos, et al.
Published: (2000-04-01)

Mycobacterium ulcerans Disease (Buruli ulcer) in Rural Hospital, Southern Benin, 1997–2001
by: Martine Debacker, et al.
Published: (2004-08-01)

Distribution of Mycobacterium ulcerans in buruli ulcer endemic and non-endemic aquatic sites in Ghana.
by: Heather R Williamson, et al.
Published: (2008-03-01)

Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa)
by: Esaï Gimatal Anagonou, et al.
Published: (2019-03-01)

Antimycobacterial activity of medicinal plants against the causative agent of buruli ulcer: Mycobacterium ulcerans
by: R Keumoe, et al.
Published: (2016-01-01)

Fish and amphibians as potential reservoirs of Mycobacterium ulcerans, the causative agent of Buruli ulcer disease
by: Mark Eric Benbow, et al.
Published: (2013-02-01)

Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
by: Alexandra G Fraga, et al.
Published: (2012-01-01)

Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.
by: Sophie Gryseels, et al.
Published: (2012-01-01)

Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients.
by: Arianna Andreoli, et al.
Published: (2014-04-01)

Exploiting reductive evolution in Mycobacterium ulcerans to develop a single-dose cure for Buruli ulcer
by: Sangeeta, Susan Thomas
Published: (2021)

Comparison of Mycobacterium ulcerans (Buruli ulcer) and Leptospira sp. (Leptospirosis) dynamics in urban and rural settings.
by: Marine Combe, et al.
Published: (2019-01-01)

Mycobacterium ulcerans not detected by PCR on human skin in Buruli ulcer endemic areas of south eastern Australia.
by: Anita Velink, et al.
Published: (2023-10-01)

Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo.
by: Delphin Mavinga Phanzu, et al.
Published: (2013-01-01)

The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
by: Yang Liu, et al.
Published: (2019-01-01)

Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969–2013: an epidemiological study
by: Maylis Douine, MD, et al.
Published: (2017-05-01)

The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon.
by: Yolanda K Mueller, et al.
Published: (2016-04-01)

Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon.
by: Martin W Bratschi, et al.
Published: (2013-01-01)